Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors [Phase 1]
NiKang Therapeutics is conducting a Phase 1 study of NKT3964 in adults with advanced or metastatic solid tumors, and the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer [Phase 1, Phase 2]
Ongoing Phase 1/2 trial update evaluating iadademstat in combination with atezolizumab or durvalumab for extensive-stage small cell lung can…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 [Phase 2]
Phase 2 study evaluating Tarlatamab in pretreated extensive-stage small cell lung cancer with ECOG performance status 2 is currently recruit…
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer
Daiichi Sankyo offers a medical access program for Ifinatamab Deruxtecan in third-line or later extensive-stage small cell lung cancer, with…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy [Phase 3]
Phase 3 trial (DAREON-Lung-1) evaluating Obrixtamig plus atezolizumab with carboplatin and etoposide versus standard chemotherapy in advance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing [Phase 1]
Phase 1 clinical trial investigating therapeutic drug monitoring-based dosing of atezolizumab across multiple cancers, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer [Phase 2, Phase 3]
Pfizer is conducting the Symbiotic-Lung-04 trial to evaluate PF-08634404 in combination with chemotherapy for adults with extensive-stage sm…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002) [Phase 1, Phase 2]
This clinical trial update reports the ongoing Phase 1/2 study evaluating Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in relapsed/…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating SGN-CEACAM5C in adults with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating Benmelstobart in combination with Anlotinib, chemotherapy, and thoracic radiation for limited-stage small cell lung…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer [Phase 2]
Pfizer is conducting a Phase 2 study of PF08634404 in combination with chemotherapy for transformed small cell lung cancer, and the trial is…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of Benmelstobart, Anlotinib, Chemotherapy and Thoracic Radiotherapy for People With Extensive-stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Benmelstobart and Anlotinib in combination with chemotherapy and thoracic radiotherapy for extensive-stage…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy [Phase 2]
Phase 2 trial update reporting safety and early effectiveness signals for BNT327 in combination with chemotherapy for small-cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies [Phase 1]
Phase 1 trial evaluating CTX-471 as a monotherapy or in combination with pembrolizumab in patients who progressed after PD-1/PD-L1 inhibitor…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study of LY4175408 in Participants With Advanced Cancer [Phase 1]
A Phase 1 clinical trial evaluating LY4175408 in participants with advanced cancers, including non-small cell lung cancer, small cell lung c…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03) [Phase 3]
Phase 3 trial comparing BL-B01D1 to Topotecan in recurrent small cell lung cancer is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma [Phase 1]
Pfizer is conducting a Phase 1 study of mevrometostat for relapsed/refractory small cell lung cancer, metastatic castration-resistant prosta…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: The Effect of Pulmonary Rehabilitation on Pulmonary Function Tests, Exercise Capacity, and Quality of Life in Patients With Advanced-Stage Lung Cancer Receiving Chemotherapy [NA]
The document reports the completion of a clinical trial evaluating whether pulmonary rehabilitation improves lung function tests, exercise c…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC) [Phase 1]
Phase 1 study evaluating tarlatamab and ZL-1310, with or without anti-PD-L1, in small cell lung cancer; the trial is not yet recruiting.
-
CLINICAL_TRIALS other · 2026-04-15Clinical Trial Update: ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/Phase 2 study of ADI-PEG 20 in combination with gemcitabine and docetaxel for patients with …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) [Phase 3]
A Phase 3 clinical trial evaluating tarlatamab after chemoradiotherapy in limited-stage small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer [Phase 1]
Phase 1 trial assessing the tolerability of BI 764532 at multiple dose levels when added to standard of care in adults with advanced small c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer [Phase 2]
This Phase 2 trial is evaluating the optimal dose, adverse events, and changes in disease activity of ABBV-706 in combination with atezolizu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
A clinical trial update indicates ongoing recruitment for a study evaluating cardiopulmonary exercise testing in lung cancer patients before…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PF-07104091 as a Single Agent and in Combination Therapy [Phase 2]
Pfizer's PF-07104091 is being studied as a single agent and in combination therapy in Phase 2 trials for small cell lung cancer, ovarian can…